Galectin-3 binding protein stimulated IL-6 expression is impeded by antibody intervention in SARS-CoV-2 susceptible cell lines

COVID-19 is the global pandemic that affected our population in the past 2 years. Considerable research has been done to better understand the pathophysiology of this disease and to identify new therapeutic targets, especially for severe cases. Galectin-3 (Gal-3) is a receptor present at the surface...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendes-Frias, Ana, Gallo, Valentina, Iacobelli, Valentina, Gentile, Roberta, Antonini, Giovanni, Silvestre, Ricardo, Iacobelli, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553085/
https://www.ncbi.nlm.nih.gov/pubmed/36220879
http://dx.doi.org/10.1038/s41598-022-20852-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553085/
https://www.ncbi.nlm.nih.gov/pubmed/36220879
http://dx.doi.org/10.1038/s41598-022-20852-x

Ejemplares similares